P&FT

official impact factor 4.91

Open Access Research

Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells

Solenne Taront1, Audrey Dieudonné1, Simon Blanchard2, Pascale Jeannin2,3, Philippe Lassalle1, Yves Delneste2,3 and Philippe Gosset1*

Author Affiliations

1 INSERM, U774, Lille, F-59019, France; Institut Pasteur de Lille, Lille, F-59019, France; Univ Lille II, Lille, F-59000 France

2 INSERM U892, Centre de Recherche sur le Cancer Nantes Angers, Angers F-49933, France; University of Angers, Angers, France

3 Immunology and Allergology department, University Hospital of Angers, Angers, 49933, France

For all author emails, please log on.

Particle and Fibre Toxicology 2009, 6:9 doi:10.1186/1743-8977-6-9

Published: 13 March 2009

Abstract

Background

The exposure to pollutants such as diesel exhaust particles (DEP) is associated with an increased incidence of respiratory diseases. However, the mechanisms by which DEP have an effect on human health are not completely understood. In addition to their action on macrophages and airway epithelial cells, DEP also modulate the functions of dendritic cells (DC). These professional antigen-presenting cells are able to discriminate unmodified self from non-self thanks to pattern recognition receptors such as the Toll like Receptors (TLR) and Scavenger Receptors (SR). SR were originally identified by their ability to bind and internalize modified lipoproteins and microorganisms but also particles and TLR agonists. In this study, we assessed the implication of SR in the effects of DEP associated or not with TLR agonists on monocyte-derived DC (MDDC). For this, we studied the regulation of CD36, CXCL16, LOX-1, SR-A1 and SR-B1 expression on MDDC treated with DEP associated or not with TLR2, 3 and 4 ligands. Then, the capacity of SR ligands (dextran sulfate and maleylated-ovalbumin) to block the effects of DEP on the function of lipopolysaccharide (LPS)-activated DC has been evaluated.

Results

Our data demonstrate that TLR2 agonists mainly augmented CXCL16, LOX-1 and SR-B1 expression whereas DEP alone had only a weak effect. Interestingly, DEP modulated the action of TLR2 and TLR4 ligands on the expression of LOX-1 and SR-B1. Pretreatment with the SR ligand maleylated-ovalbumin but not dextran sulfate inhibited the endocytosis of DEP by MDDC. Moreover, this SR ligand blocked the effect by DEP at low dose (1 μg/ml) on MDDC phenotype (a decrease of CD86 and HLA-DR expression) and on the secretion of CXCL10, IL-12 and TNF-α. In contrast, the decrease of IL-12 and CXCL10 secretion and the generation of oxygen metabolite induced by DEP at 10 μg/ml was not affected by SR ligands

Conclusion

Our results show for the first time that the modulation of DC functions by DEP implicates SR. TLR agonists upregulated SR expression in contrast to DEP. Interfering with the expression and/or the function of SR might be one way to limit the impact of DEP on lung immune response.